Le Cong

Biology is entering an era where AI agents don’t just analyze data — they co-design, plan, and execute experiments. Multi-agent systems like CRISPR-GPT demonstrate how AI can act as a true lab co-pilot: decomposing complex genome editing projects into stepwise workflows, selecting tools, troubleshooting, and even drafting protocols that allow junior researchers to perform sophisticated edits on their first attempt . Beyond CRISPR, new systems like BioMARS integrate reasoning agents with robotics, while biotech companies are testing “AI lab assistants” that monitor and adjust experiments in real time. This session explores how multi-agent copilots are making biology more reproducible, democratizing complex workflows, and pushing the boundaries of lab autonomy. The central question: when AI can plan, troubleshoot, and validate experiments end-to-end, how should scientists and institutions govern this new power?

Join Stanford’s Le Cong for an immersive, hands-on masterclass exploring how CRISPR, genome engineering, and next-generation biological foundation models are converging to redefine programmable biology. This live CRISPR-GPT - LabOS/LabClaw Workshop will walk attendees through emerging AI-assisted editing workflows that pair large biological language models with precise genome engineering tools to accelerate design, improve specificity, and unlock new editing modalities. Participants will step inside real CRISPR-GPT workflows to see how LabOS/LabClaw-style systems can help interpret genomic context, predict repair outcomes, suggest optimized guide designs, and generate editing strategies for complex loci. Le Cong will demonstrate how AI-driven reasoning is beginning to streamline experimental planning, reduce screening burden, and push forward new frontiers in base editing, prime editing, and programmable gene modulation. This session is designed for scientists, engineers, founders, and R&D leaders who want to understand how AI-powered CRISPR design actually works in practice, and how tools like CRISPR-GPT, LabOS, and LabClaw can accelerate therapeutic development, functional genomics, and next-generation editing technologies.